author-photo

Jörg Kreuzer

Boehringer Ingelheim

24

Papers

1043

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.

2020 The Lancet Haematology
Show All
- Source
- Cite
- Save
Citations (14)
Dabigatran Etexilate for the Treatment of Acute Venous Thromboembolism in Children: Results of an Open-Label, Phase 2b/3, Randomised Clinical Trial

2020 Social Science Research Network
Show All
- Source
- Cite
- Save
Citations (0)
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source

2019 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (279)
Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery: A Subanalysis of the RE-VERSE AD Study

2019 Annals of Surgery
Show All
- Source
- Cite
- Save
Citations (6)
Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.

2019 Blood
Show All
- Source
- Cite
- Save
Citations (25)
Abstract 15113: Idarucizumab in Dabigatran-Treated Patients Requiring Emergency Surgery or Intervention: Updated/Final Results From the RE-VERSE AD Study

2017 Circulation
Show All
- Source
- Cite
- Save
Citations (1)
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II

2017 Thrombosis and Haemostasis
Show All
- Source
- Cite
- Save
Citations (24)
Abstract 213: Effect of Idarucizumab on Intracranial Bleeding in Dabigatran-treated Patients: Initial Results From RE-VERSE AD

2016 Stroke
Show All
- Source
- Cite
- Save
Citations (1)
Dabigatran Is Associated with a Significantly Lower Risk of Abnormal Uterine Bleeding Than Warfarin in Female Patients of Childbearing Age with Venous Thromboembolism

2016 Blood
Show All
- Source
- Cite
- Save
Citations (5)
Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting.

2016 Clinical Cardiology
Show All
- Source
- Cite
- Save
Citations (56)